Chimin(SH:603222) Zheng Quan Shi Bao·2025-09-12 01:25Core Viewpoint - Jimin Health (603222) experienced a significant increase in stock price, reaching the daily limit, with a turnover rate of 16.96% and a transaction volume of 1.202 billion yuan, indicating strong market interest and trading activity [1][2]. Trading Activity - The stock was listed on the Shanghai Stock Exchange's daily trading report due to a price fluctuation of 18.35%, with a net buying amount of 66.0795 million yuan from brokerage seats [1]. - The top five brokerage seats accounted for a total transaction volume of 289 million yuan, with a buying amount of 178 million yuan and a selling amount of 111 million yuan, resulting in a net buying of 66.0795 million yuan [1][2]. - The largest buying brokerage was Huafu Securities, with a purchase amount of 59.0385 million yuan, while the largest selling brokerage was CITIC Securities, with a selling amount of 46.6849 million yuan [3]. Fund Flow - The stock saw a net inflow of 237 million yuan from major funds today, with a significant inflow of 263 million yuan from large orders, while smaller orders saw a net outflow of 25.9314 million yuan [2]. - Over the past five days, the stock has experienced a total net inflow of 290 million yuan [2]. Margin Trading Data - As of September 10, the margin trading balance for the stock was 197 million yuan, with a financing balance of 197 million yuan and a securities lending balance of 115,000 yuan [2]. - In the last five days, the financing balance increased by 224,900 yuan, reflecting a growth rate of 0.11%, while the securities lending balance increased by 22,900 yuan, with a growth rate of 24.84% [2]. Financial Performance - According to the semi-annual report released on August 21, the company achieved a revenue of 366 million yuan in the first half of the year, representing a year-on-year decline of 21.30%, and reported a net loss of 52.6959 million yuan [2].